Cargando…

Targeting BRAF in thyroid cancer

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Espinosa, A V, Porchia, L, Ringel, M D
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2007
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360157/ http://dx.doi.org/10.1038/sj.bjc.6603676

Ejemplares similares

Targeting BRAF in thyroid cancer
por: Espinosa, A V, et al.
Publicado: (2007)

KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre study
por: van Grieken, N C T, et al.
Publicado: (2014)

The Blood Biomarkers of Thyroid Cancer [Corrigendum]
Publicado: (2022)

Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis [Corrigendum]
Publicado: (2017)

Biological activity of the thyroid TRK-T3 oncogene requires signalling through Shc
por: Roccato, E, et al.
Publicado: (2016)

Corrigendum to “Challenges in Interpretation of Thyroid Function Tests in Pregnant Women with Autoimmune Thyroid Disease”
por: Feldt-Rasmussen, Ulla, et al.
Publicado: (2017)

Isolation of a SIR-like gene, SIR-T8, that is overexpressed in thyroid carcinoma cell lines and tissues
por: de Nigris, F, et al.
Publicado: (2002)

Corrigendum to ‘How I treat medullary thyroid cancer’: [ESMO Open Volume 6, Issue 3, June 2021, 100183]
por: Kiesewetter, B., et al.
Publicado: (2022)

NECTIN4 Promotes Papillary Thyroid Cancer Cell Proliferation, Migration, and Invasion and Triggers EMT by Activating AKT [Corrigendum]
Publicado: (2019)

Human thyroid tumours, the puzzling lessons from E7 and RET/PTC3 transgenic mice
por: Jin, L, et al.
Publicado: (2009)

Corrigendum to: The Role of Iodine for Thyroid Function in Lactating Women and Infants
Publicado: (2022)

FUCA1 is induced by wild-type p53 and expressed at different levels in thyroid cancers depending on p53 status
Publicado: (2017)

miR-27a-3p regulates the inhibitory influence of endothelin 3 on the tumorigenesis of papillary thyroid cancer cells
por: Chen, Hongxin, et al.
Publicado: (2021)

Corrigendum: Affiliation Correction. Development and Validation of a Risk Scoring System Derived from Meta-Analyses for Papillary Thyroid Cancer
por: Suh, Sunghwan, et al.
Publicado: (2023)

Corrigendum to “Impact of Diabetic Ketoacidosis on Thyroid Function in Patients with Diabetes Mellitus”
por: Xing, Yuling, et al.
Publicado: (2021)

Corrigendum: Abstract and Text Correction. Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015
por: Kim, Won Gu, et al.
Publicado: (2023)

Corrigendum to “How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer”
por: Prazeres, Hugo, et al.
Publicado: (2016)

Corrigendum to: Optimisation of follow-up in patients with papillary thyroid cancer who show no evidence of disease 9 to 12 months after treatment
por: Nordell, Fabian, et al.
Publicado: (2022)

Corrigendum to “Impaired Fertility Associated with Subclinical Hypothyroidism and Thyroid Autoimmunity: The Danish General Suburban Population Study”
por: Feldthusen, Anne-Dorthe, et al.
Publicado: (2017)

Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153]
por: Park, Ki Cheong, et al.
Publicado: (2017)

Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma
por: Jeon, Min Ji, et al.
Publicado: (2022)

Corrigendum to “There Is No Elevation of Immunoglobulin E Levels in Albanian Patients with Autoimmune Thyroid Diseases”
por: Latifi-Pupovci, Hatixhe, et al.
Publicado: (2022)

Thyroid hormones enhance growth and counteract apoptosis in human tenocytes isolated from rotator cuff tendons
por: Oliva, F, et al.
Publicado: (2014)

Corrigendum to “Factors Associated with the Prevalence of Thyroid Nodules and Goiter in Middle-Aged Euthyroid Subjects”
por: Dauksiene, Dalia, et al.
Publicado: (2019)

Corrigendum For: “Effect of Plasma Exchange in Thyroid Storm With Consideration of Its Distribution Into the Extravascular Space”
Publicado: (2020)

Corrigendum to “Thyroid Hormone Changes in the Northern Area of Tianjin during the COVID-19 Pandemic”
por: Weiwei, Dong, et al.
Publicado: (2022)

Corrigendum to “A Novel Neutrosophic Method for Automatic Seed Point Selection in Thyroid Nodule Images”
por: Haji, S. O., et al.
Publicado: (2019)

Addition of funding statement: Clinical characteristics of papillary thyroid carcinoma arising from the pyramidal lobe
por: Yoon, Sang Gab, et al.
Publicado: (2017)

miR-505 suppresses prostate cancer progression by targeting NRCAM
por: Ling, Xiao-Hui, et al.
Publicado: (2020)

Orbital decompression in the system of treatment for complicated thyroid eye disease: case report and literature review [corrigendum]
Publicado: (2019)

Autophagy as a new therapeutic target in Duchenne muscular dystrophy
por: De Palma, C, et al.
Publicado: (2013)

MicroRNA-1258: An invasion and metastasis regulator that targets heparanase in gastric cancer
por: Shi, Jinxin, et al.
Publicado: (2021)

Corrigendum to “A general Bayesian treatment for MEG source reconstruction incorporating lead field uncertainty” [Neuroimge 60/2 (2012) 1194–1204]
por: López, J.D., et al.
Publicado: (2013)

siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma
por: de Martimprey, Henri, et al.
Publicado: (2008)

Protocol for a Korean Multicenter Prospective Cohort Study of Active Surveillance or Surgery (KoMPASS) in Papillary Thyroid Microcarcinoma
por: Jeon, Min Ji, et al.
Publicado: (2022)

Upregulated LINC00565 Accelerates Ovarian Cancer Progression by Targeting GAS6 [Corrigendum]
Publicado: (2020)

Corrigendum: Tumour‐associated macrophages as a novel target of VEGI‐251 in cancer therapy
Publicado: (2022)

miR-370 regulates cell proliferation and migration by targeting EGFR in gastric cancer
por: Ning, Tao, et al.
Publicado: (2022)

Subcellular Organelle-Targeted Nanostructured Lipid Carriers for the Treatment of Metastatic Breast Cancer [Corrigendum]
Publicado: (2023)

The Utility of BRAF Testing in the Management of Papillary Thyroid Cancer
por: Melck, Adrienne L., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9e6amnkshpn74iudf35easpt06